Blood bank software interface research is best understood as a set of workflow and validation questions rather than a product comparison. The primary documents describe distinct integration layers: a blood bank laboratory information system feeding status into an electronic health record, middleware connecting instruments to a laboratory system, and remote dispensing devices that depend on informatics logic. Each layer has different failure modes, evidence quality, and decision points. A 2025 Transfusion brief report documents one institution's EHR-based blood tracker, while FDA guidance and a 510(k) summary describe validation and middleware functions. Usability research adds measured error reduction but with single-site limits. The practical question is which interface decisions are supported by documented outcomes and which remain untested.

The EHR Status Tracker as an Interface Outcome

Vanderbilt University Medical Center built a blood product tracker that pulls real-time information from its blood bank laboratory information system into a Transfusion Dashboard and Storyboard within the EHR [1][5]. The tracker displays status from order printed through preparing to on its way, modeled on commercial package trackers for e-commerce and food delivery [1][5]. The design team included physicians, nurses, health IT staff, blood bank leadership, quality improvement leadership, and Transfusion Safety Officers [1]. This composition matters because the interface had to satisfy clinical visibility needs and laboratory workflow constraints simultaneously.

Usage data showed the tracker was viewed 109,626 times per month on average from January through December 2023, comparable to Patient Summary and Meds History reports at the same site [1][5]. The technologist survey found that before implementation, 65% of respondents received over 10 calls per shift, with a positive relationship between call volume and distraction [1][5]. Six months after go-live, the fraction receiving over 21 calls per shift decreased from 39% to 20% [1][5]. These figures describe one academic medical center's experience and do not establish that other organizations would see the same reduction.

Middleware and Instrument Interface Boundaries

The ImmuLINK v3.3 510(k) summary describes software that provides an interface between the operator, blood bank automated and semi-automated instruments, and Blood Establishment Computer Software such as a laboratory information system [6]. The document states that ImmuLINK allows integration of sample, donor, or patient data collected from multiple sources and provides data management tools for customizable reports [6]. It is configurable to interface with multiple instrument platforms, including Immucor's Galileo Neo, NEO Iris, Galileo Echo, and Echo Lumena systems [6].

The 510(k) summary also specifies what the middleware does not do. ImmuLINK does not provide diagnostic interpretations of antibodies; final interpretation must be performed by a trained user [6]. The document lists bi-directional communication between an LIS and instrument platforms, remote validation of test results before delivery to an LIS, and an antibody exclusion and identification tool based on the approach recommended in the AABB Technical Manual [6]. These statements are vendor-submitted regulatory documentation, not independent performance evidence.

A Suggested Interface Evaluation Scenario

A transfusion service could evaluate an EHR status tracker by first mapping the exact status transitions its blood bank laboratory information system can emit. The Vanderbilt report shows statuses from order printed to preparing to on its way, but other systems may expose different states [1][5]. A suggested test would involve a simulated urgent order during a staff shortage, with a technologist recording whether the displayed status matches the actual unit location at each transition. This is a suggestion, not a documented protocol.

For middleware, a facility could follow the FDA guidance structure by writing test cases for a result posting to the wrong patient record and an order that fails to transmit [3]. The test plan would record expected output, actual output, acceptance criteria, and tester identification for each case [3]. For remote dispensing, the evaluation would need to specify whether the workflow uses Remote Assignment or Remote Allocation, since the informatics logic differs [7]. None of these steps should be treated as validated without local testing.

Validation Requirements and Interface Risk

FDA guidance on blood establishment computer system validation in the user's facility is nonbinding but describes current agency thinking [3]. The guidance recommends performing validation in a test environment or test partition, then copying the validated file configuration into production [3]. Each executed test case should include input, expected output, actual output, acceptance criteria, pass or fail status, tester identification, and date [3]. Test cases should cover normal results, abnormal results, and boundary values [3].

The guidance also addresses interface-specific failure modes. It recommends testing at simulated peak production times with the maximum number of concurrent users [3]. It calls attention to problems such as orders not being received or results posting to the incorrect donor or patient record [3]. Personnel training must include the ability to respond to alarms, warnings, and error messages [3]. The guidance recommends validating data conversion from a legacy system to avoid duplicate donor records and deferral codes [3]. These recommendations apply to the user facility, not to the software developer's own validation.

Usability Testing and Ordering Error Reduction

A formative usability study at Children's Healthcare of Atlanta compared an original blood product ordering design with a user-centered design developed by 29 stakeholders across clinical, laboratory, and IT departments [4]. The committee condensed multiple blood product order sets for different clinical settings into a single unified blood administration order set [4]. Summative testing with 7 participants and 28 scenarios for the original design and 8 participants and 32 scenarios for the user-centered design found task completion with no errors rose from 35.7% to 65.6% [4].

Severe errors per scenario decreased from 0.5 to 0.125, while moderate errors were essentially unchanged at 0.29 and 0.28 [4]. The authors note the study is limited by a small sample size at a single institution with unique considerations and constraints [4]. They also state the design may have been overfit to the scenarios created by the authors and targeted error types, with unanticipated effects possible in untested clinical situations [4]. The blood bank maintained independent lists of patients requiring special processing as an additional safety layer [4].

Remote Dispensing and Informatics Logic

A multi-institutional survey of North American institutions using BloodTrack-integrated smart refrigerators describes how Remote Assignment, Remote Allocation, and BloodTrack Enquiry define the interface between smart refrigerators and the blood bank information system [7]. The authors state that effective use depends on device placement, workflow design, and understanding the informatics logic governing product selection, crossmatching, and dispensing [7]. BloodTrack Enquiry supports single sign-on with automatic transmission of the patient's medical record number, eliminating separate logins or manual patient lookup [7].

The survey was developed and internally validated by experienced BloodTrack users at Weill Cornell Medicine in summer 2024 and distributed by Haemonetics via email to 153 BloodTrack customer sites [7]. Responses were collected anonymously using Qualtrics and reviewed exclusively by Weill Cornell investigators [7]. The published abstract describes real-world implementation strategies and operational variability but does not provide response rates or outcome measures in the retrieved passages. The vendor's role in distribution is a relevant limitation for interpreting representativeness.